These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 7033016

  • 1. Benzbromarone therapy in hyperuricaemia; comparison with allopurinol and probenecid.
    Schepers GW.
    J Int Med Res; 1981; 9(6):511-5. PubMed ID: 7033016
    [Abstract] [Full Text] [Related]

  • 2. [The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].
    Mertz DP.
    MMW Munch Med Wochenschr; 1978 Oct 20; 120(42):1387-90. PubMed ID: 101792
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK, van Roon EN, Jansen TL, Delsing J, Griep EN, Hoekstra M, van de Laar MA, Brouwers JR.
    Ann Rheum Dis; 2009 Jan 20; 68(1):51-6. PubMed ID: 18250112
    [Abstract] [Full Text] [Related]

  • 4. [Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].
    Arntz HR, Dreykluft HR, Leonhardt H.
    Fortschr Med; 1979 Jul 19; 97(27):1212-4. PubMed ID: 457017
    [Abstract] [Full Text] [Related]

  • 5. Benzbromarone therapy in hyperuricaemia.
    Scott WA.
    J Int Med Res; 1981 Jul 19; 9(1):82-7. PubMed ID: 7009259
    [Abstract] [Full Text] [Related]

  • 6. Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients.
    Reinders MK, van Roon EN, Houtman PM, Brouwers JR, Jansen TL.
    Clin Rheumatol; 2007 Sep 19; 26(9):1459-65. PubMed ID: 17308859
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)].
    Matzkies F, Berg G.
    Dtsch Med Wochenschr; 1976 Oct 22; 101(43):1568-70. PubMed ID: 991731
    [Abstract] [Full Text] [Related]

  • 8. [Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)].
    Mertz DP.
    Dtsch Med Wochenschr; 1976 Aug 27; 101(35):1288-92. PubMed ID: 782809
    [No Abstract] [Full Text] [Related]

  • 9. [Uric acid lowering effects of benzbromarone (Harolan) by increasing uric acid excretion].
    Fortschr Med; 1979 May 03; 97(17):835-6. PubMed ID: 437646
    [No Abstract] [Full Text] [Related]

  • 10. Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia.
    Heel RC, Brogden RN, Speight TM, Avery GS.
    Drugs; 1977 Nov 03; 14(5):349-66. PubMed ID: 338280
    [Abstract] [Full Text] [Related]

  • 11. [The effect on uric acid and other laboratory parameters. A long-term study].
    Dorn M.
    ZFA (Stuttgart); 1982 Feb 20; 58(5):296-300. PubMed ID: 7043937
    [No Abstract] [Full Text] [Related]

  • 12. Does benzbromarone in therapeutic doses raise renal excretion of oxipurinol?
    Mertz DP, Eichhorn R.
    Klin Wochenschr; 1984 Dec 17; 62(24):1170-2. PubMed ID: 6530890
    [Abstract] [Full Text] [Related]

  • 13. Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial.
    McMullan CJ, Borgi L, Fisher N, Curhan G, Forman J.
    Clin J Am Soc Nephrol; 2017 May 08; 12(5):807-816. PubMed ID: 28320765
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of purine catabolism by benzbromarone in isolated rat liver cells. Comparison with allopurinol and probenecid.
    Rodilla F, Sanchez-Beltran MJ, Izquierdo R, Gomez-Ruiz MD, Cabo J.
    Biochem Pharmacol; 1988 Oct 01; 37(19):3561-3. PubMed ID: 3178870
    [Abstract] [Full Text] [Related]

  • 15. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
    Mertz DP.
    Med Klin; 1977 Apr 15; 72(15):664-8. PubMed ID: 857138
    [Abstract] [Full Text] [Related]

  • 16. [Allomaron in hyperuricemia and gout].
    Barsom S.
    ZFA (Stuttgart); 1979 Aug 31; 55(24):1336-40. PubMed ID: 539082
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P, Akkasilpa S, Deesomchok U.
    J Med Assoc Thai; 2002 Jun 31; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [Abstract] [Full Text] [Related]

  • 18. [Management of hyperuricemia in diabetes].
    Hirai A, Saito Y.
    Nihon Rinsho; 1997 Nov 31; 55 Suppl():781-5. PubMed ID: 9434564
    [No Abstract] [Full Text] [Related]

  • 19. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
    Mertz DP.
    Fortschr Med; 1983 May 12; 101(18):851-3. PubMed ID: 6862346
    [No Abstract] [Full Text] [Related]

  • 20. Letter: A clinical impression of benzbromarone (Minuric).
    Allwright GT.
    S Afr Med J; 1974 Nov 16; 48(56):2301. PubMed ID: 4439104
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.